DNA microarray analysis of gene expression profiles in deep endometriosis using laser capture microdissection

Molecular Human Reproduction

Volumn 10, Issue 10, 2004, Pages 719-728

  Matsuzaki, S ^a,b   Canis, M ^a   Vaurs Barriere C ^c   Pouly, J L ^a   Boespflug Tanguy, O ^c   Penault Llorca, F ^d   Dechelotte, P ^a   Dastugue, B ^c   Okamura, K ^b   Mage, G ^a  

^a HÔTEL DIEU   (France)

^b TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c INSERM   (France)

^d CENTRE JEAN PERRIN   (France)

Author keywords

cDNA microarray; Endometriosis; Endometrium; Laser capture microdissection

Indexed keywords

AROMATASE; CHICKEN OVALBUMIN UPSTREAM PROMOTER TRANSCRIPTION FACTOR; COMPLEMENTARY DNA; DNA; ESTROGEN; JANUS KINASE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 7; MU OPIATE RECEPTOR; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PROSTAGLANDIN E RECEPTOR; PROTEIN KINASE C BETA; RAF PROTEIN; RAS PROTEIN; RECEPTOR SUBTYPE; SEROTONIN TRANSPORTER; TYROSINE KINASE RECEPTOR; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA DETERMINATION; DNA MICROARRAY; ENDOMETRIOSIS; ENDOMETRIUM; EPITHELIUM CELL; ESTROGEN SYNTHESIS; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE SYSTEM; LAPAROSCOPIC SURGERY; LAPAROTOMY; LASER CAPTURE MICRODISSECTION; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STROMA CELL;

GALLUS GALLUS; JANUS;

EID: 5044244642     PISSN: 13609947     EISSN: None     Source Type: Journal    
DOI: 10.1093/molehr/gah097     Document Type: Article

References (65)

1. Aboseif S, El-Sakka A, Young P and Cunha G (1999) Mesenchymal reprogramming of adult human epithelial differentiation. Differentiation 65, 113-118.
2. American Society for Reproductive Medicine (1997) Revised American Society for Reproductive Medicine classification of endometriosis: 1996. Fertil Steril 67,817-821.
3. Anaf V, Simon P, El Nakadi I, Fayt I, Buxant F, Simonart T, Peny MO and Noel JC (2000) Relationship between endometriotic foci and nerves in rectovaginal endometriotic nodules. Hum Reprod 15,1744-1750.
4. Anaf V, Simon P, El Nakadi I, Fayt I, Simonart T, Buxant F and Noel JC (2002) Hyperalgesia, nerve infiltration and nerve growth factor expression in deep adenomyotic nodules, peritoneal and ovarian endometriosis. Hum Reprod 17,1895-1900.
5. Baugh LR, Hill AA, Brown EL and Hunter CP (2001) Quantitative analysis of mRNA amplification by in vitro transcription. Nucleic Acids Res 29,E29.
6. Bagatell R, Khan O, Paine-Murrieta G, Taylor CW, Akinaga S and Whitesell L (2001) Human breast tumor xenografts in SCID mice. Clin Cancer Res 7,2076-2084.
7. Bergers G, Song S, Meyer-Morse N, Bergsland E and Hanahan D (2003) Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors. J Clin Invest 111,1287-1295.
8. Bonner RF, Emmert-Buck M, Cole K, Pohida T, Chuaqui R, Goldstein S and Liotta LA (1997) Laser capture dissection: molecular analysis of tissue. Science 278,1481-1482.
9. Bohen SP and Yamamot KR (1994) The biology of heat shock proteins and molecular chaperones. In Morimoto RI, Tissieres A, and Georgopoulos C (eds), Stress proteins in biology and medicine. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, pp. 313-334.
10. Breyer RM, Bagdassarian CK, Myers SA and Breyer MD (2001) Prostanoid receptors: subtypes and signaling. Annu Rev Pharmacol Toxicol 41, 661-690.
11. Brown PO and Botstein D (1999) Exploring the new world of the genome with DNA microarrays. Nat Genet 21,33-37.
12. Cao MY, Shinjo F, Heinrichs S, Soh JW, Jongstra-Bilen J and Jongstra J (2001) Inhibition of anti-IgM-induced translocation of protein kinase C beta I inhibits ERK2 activation and increases apoptosis. J Biol Chem 276,24506-24510.
13. Cao R, Brakenhielm E, Pawliuk R, Wariaro D, Post MJ, Wahlberg E, Leboulch P and Cao Y (2003) Angiogenic synergism, vascular stability and improvement of hind-limb ischemia by a combination of PDGF-BB and FGF-2. Nat Med 9,604-613.
14. Chott A, Sun Z, Morganstern D, Pan J, Li T, Susani M, Mosberger I, Upton MP, Bubley GJ and Balk SP (1999) Tyrosine kinases expressed in vivo by human prostate cancer bone marrow metastases and loss of the type 1 insulin-like growth factor receptor. Am J Pathol 155, 1271-1279.
15. Claverie JM (1999) Computational methods for the identification of differential and coordinated gene expression. Hum Mol Genet 8,1821-1833.
16. Clemeny PB (1994) Disease of the peritoneum. In Kurman RJ (ed.), Blaustein's pathology of the female genital tract. Springer-Verlag, New York, NY, pp. 660-680.
17. Dalal R and Djakiew D (1997) Molecular characterization of neurotrophin expression and the corresponding tropomyosin receptor kinases (trks) in epithelial and stromal cells of the human prostate. Mol Cell Endocrinol 134,15-22.
18. Emmert-Buck MR, Bonner RF, Smith PD, Chuaqui RF, Zhuang Z, Goldstein SR, Weiss RA and Liotta LA (1996) Laser capture microdissection. Science 274,998-1001.
19. Eskenazi B and Warner ML (1997) Epidemiology of endometriosis. Obstet Gynecol Clin North Am 24,235-258.
20. Feldman AL, Costouros NG, Wang E, Qian M, Marincola FM, Alexander HR and Libutti SK (2002) Advantages of mRNA amplification for microarray analysis. Biotechniques 33,906-912.
21. Gaetje R, Kotzian S, Herrmann G, Baumann R and Starzinski-Powitz A (1995) Invasiveness of endometriotic cells in vitro. Lancet 346, 1463-1464.
22. Harada T, Iwabe T and Terakawa N (2001) Role of cytokines in endometriosis. Fertil Steril 76, 1-10.
23. Healy DL, Rogers PA, Hii L and Wingfield M (1998) Angiogenesis: a new theory for endometriosis. Hum Reprod Update 4,736-740.
24. Heldin CH and Westermark B (1999) Mechanism of action and in vivo role of platelet-derived growth factor. Physiol Rev 79,1283-1316.
25. Iyer VR, Eisen MB, Ross DT, Schuler G, Moore T, Lee JCF, Trent JM, Staudt LM, Hudson J Jr and Boguski MS (1999) The transcriptional program in the response of human fibroblasts to serum. Science 283, 83-87.
26. Jones RK, Bulmer JN and Searle RF (1998) Phenotypic and functional studies of leukocytes in human endometrium and endometriosis. Hum Reprod Update 4,702-709.
27. Kawakami Y, Kitaura J, Yao L, Mc Henry RW, Kawakami Y, Newton AC, Kang S, Kato RM, Leitges M and Rawilngs DJ (2003) A Ras activation pathway dependent on Syk phosphorylation of protein kinase C. Proc Natl Acad Sci USA 100,9470-9475.
28. Koninckx PR and Martin D (1994) Treatment of deeply infiltrating endometriosis. Curr Opin Obstet Gynecol 6,231-241.
29. Kraus J, Borner C, Giannini E and Hollt V (2003) The role of nuclear factor kappaB in tumor necrosis factor-regulated transcription of the human mu-opioid receptor gene. Mol Pharmacol 64,876-884.
30. Kress M and Reeh PW (1996) Chemical excitation and sensitization in nociceptors. In Cervero F and Belmonte C (eds), Neurobiology of nociceptors. Oxford University Press, New York, NY, pp. 258-297.
31. Lebovic DI, Mueller MD and Taylor RN (2001) Immunobiology of endometriosis. Fertil Steril 75,1-10.
32. Liotta LA and Kohn EC (2001) The microenvironment of the tumour-host interface. Nature 411,375-379.
33. Luo L, Salunga RC, Guo H, Bittner A, Joy KC, Galindo JE, Xiao H, Rogers KE, Wan JS and Jackson MR (1999) Gene expression profiles of laser-captured adjacent neuronal subtypes. Nat Med 1,117-122.
34. Luzzi V, Holtschlag V and Watson MA (2001) Expression profiling of ductal carcinoma in situ by laser capture microdissection and high-density oligonucleotide arrays. Am J Pathol 158,2005-2010.
35. Luzzi V, Mahadevappa M, Raja R, Warrington JA and Watson MA (2003) Accurate and reproducible gene expression profiles from laser capture microdissection, transcript amplification, and high density oligonucleotide microarray analysis. J Mol Diagn 5,9-14.
36. MacDonald TJ, Brown KM, LaFleur B, Peterson K, Lawlor C, Chen Y, Packer RJ, Cogen P and Stephan DA (2001) Expression profiling of medulloblastoma: PDGFRA and the RAS/MAPK pathway as therapeutic targets for metastatic disease. Nat Genet 29,143-152.
37. Marshall CJ (1995) Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 80, 179-185.
38. Murphy AA (2002) Clinical aspects of endometriosis. Ann NY Acad Sci 955,1-10.
39. Nisolle M and Donnez J (1997) Peritoneal endometriosis, ovarian endometriosis, and adenomyotic nodules of the rectovaginal septum are three different entities. Fertil Steril 68,585-596.
40. Noble LS, Simpson ER, Johns A and Bulun SE (1996) Aromatase expression in endometriosis. J Clin Endocrinol Metab 81,174-179.
41. Noble LS, Takayama K, Zeitoun KM et al. (1997) Prostaglandin E2 stimulates aromatase expression in endometriosis-derived stromal cells. J Clin Endocrinol Metab 82,600-606.
42. Noyes RW, Hertig AT and Rock J (1950) Dating the endometrial biopsy. Fertil Steril 1,3-5.
43. Olive DL and Schwartz LB (1993) Endometriosis. N Engl J Med 328, 1759-1769.
44. Pol O, Alameda F and Puig MM (2001) Inflammation enhances mu-opioid receptor transcription and expression in mice intestine. Mol Pharmacol 60,894-899.
45. Porter AC and Vaillancourt RR (1998) Tyrosine kinase receptor-activated signal transduction pathways which lead to oncogenesis. Oncogene 17, 1343-1352.
46. Richards JA and Brueggemeier RW (2003) Prostaglandin E2 regulates aromatase activity and expression in human adipose stromal cells via two distinct receptor subtypes. J Clin Endocrinol Metab 88, 2810-2816.
47. Satoh M and Minami M (1995) Molecular pharmacology of the opioid receptors. Pharmacol Ther 68,343-364.
48. Sasano H and Harada N (1998) Intratumoral aromatase in human breast, endometrial, and ovarian malignancies. Endocr Rev 19,593-607.
49. Schena M, Shalon D, Davis RW and Brown PO (1995) Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 270,467-470.
50. Schulte TW, Blagosklonny MV, Ingui C and Neckers L (1995) Disruption of the Raf-1-HSP90 molecular complex results in destablization of Raf- 1 and loss of Raf-1-ras association. J Biol Chem 270,24585-24588.
51. Segnitz B and Gehring U (1997) The function of steroid hormone receptors is inhibited by the hsp90-specific compound geldanamycin. J Biol Chem 272,18694-18701.
52. Selam B, Kayish UA, Garcia-Velasco JA, Akbas GE and Arici A (2002) Regulation of fas ligand expression by IL-8 in human endometrium. J Clin Endocrinol Metab 87,3921-3927.
53. Sibinga NE and Goldstein A (1998) Opioid peptides and opioid receptors in cells of the immune system. Annu Rev Immunol 6,219-249.
54. Stancato LF, Sakatsume M, David M, Dent P, Dong F, Petricoin EF, Krolewski JJ, Silvennoinen O, Saharinan P, and Pierce J (1997) Beta inteferone and oncostatin M activate Raf-1 and mitogen activated protein kinase through JAK-1 dependent pathway. Mol Cell Biol 17,3833-3840.
55. Stein C, Hassan AH, Lehrberger K, Giefing J and Yassouridis A (1993) Local analgesic effect of endogenous opioid peptides. Lancet 342, 321-324.
56. Vogel C, Mossner R, Gerlach M, Heinemann T, Murphy DL, Riederer P, Lesch KP and Sommer C (2003) Absence of thermal hyperalgesia in serotonin transporter-deficient mice. Neurosci 23,708-715.
57. Wang E, Miller LD, Ohnmacht GA, Liu ET and Marincola FM (2000) High-fidelity mRNA amplification for gene profiling. Nat Biotechnol 18, 457-459.
58. Wang J, Charboneau R, Barke RA, Loh HH and Roy S (2002) Mu-opioid receptor mediates chronic restraint stress-induced lymphocyte apoptosis. J Immunol 169,3630-3636.
59. Wolter S, Mushinski JF, Saboori AM, Resch K and Kracht M (2002) Inducible expression of a constitutively active mutant of mitogen-activated protein kinase kinase 7 specifically activates c-JUN NH2-terminal protein kinase, alters expression of at least nine genes, and inhibits cell proliferation. J Biol Chem 277,3576-3584.
60. Wong ES, Fong CW, Lim J, Yuso HP, Low BC, Langdon WY and Guy GR (2002) Sproutyz attenuates epidermal growth factor receptor ubquitylation and endocytosis and consequently enhances Ras/ERK signalling. EMBO J 21,4796-4808.
61. Yu J, Liu XW and Kim HR (2003) Platelet-derived growth factor (PDGF) receptor-alpha-activated c-Jun NH2-terminal kinase-1 is critical for PDGF-induced p21WAF1/CIP1 promoter activity independent of p53. J Biol Chem 278,49582-49588.
62. Yusoff P, Lao DH, Ong SH, Wong ES, Lim J, Lo TL, Leong HF, Fong CW and Guy GR (2002) Sprouty2 inhibits the Ras/MAP kinase pathway by inhibiting the activation of Raf. J Biol Chem 277,3195-3201.
63. Zeitoun K, Takayama K, Michael MD and Bulun SE (1999) Stimulation of aromatase P450 promoter (II) activity in endometriosis and its inhibition in endometrium are regulated by competitive binding of steroidogenic factor-1 and chicken ovalbumin upstream promoter transcription factor to the same cis-acting element. Mol Endocrinol 13,239-253.
64. Zeitvogel A, Baumann R and Starzinski-Powitz A (2001) Identification of an invasive. N cadherin expressing epithelial cell type in endometriosis using a new cell culture model. Am J Pathol 159,1839-1852.
65. Zondervan KT, Cardon LR and Kennedy SH (2001) The genetic basis of endometriosis. Curr Opin Obstet Gynecol 13,309-314.